Pierrepont Therapeutics, Inc. — Form D
Pierrepont Therapeutics, Inc. of BROOKLYN, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-15. The offering totals $5.9M, of which $2.1M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2024-04-15
- Form: D
- Accession: 0002019360-24-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.9M
- Amount sold: $2.1M
- Remaining: $3.8M
- Investors: 2
- Date of first sale: 2024-04-02
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-510659
Issuer
- Name: Pierrepont Therapeutics, Inc.
- CIK: 0002019360
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: DOWNSTATE TECHNOLOGY CENTER, SUITE 327A, BROOKLYN, NY, 11203
- Phone: 212-430-1740
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Peter H Barber | Director | Brooklyn, NY |
| Daniel H DiPietro | Director | Brooklyn, NY |
| Matthew H Wyckoff | Director | Brooklyn, NY |
| Peter H Barber | Executive Officer | Brooklyn, NY |
More